NCT00001688View on ClinicalTrials.gov

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 1998

Study Completion Date

November 30, 2001

Conditions
HIV Infection
Interventions
DRUG

Ritonavir

DRUG

Nevirapine

DRUG

Stavudine

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH